CSIMarket


Inmune Bio Inc  (NASDAQ: INMB)
Other Ticker:  
 

Inmune Bio Inc

INMB's Fundamental analysis








Inmune Bio Inc's sales fell in IV. Quarter 2024 from the same quarter a year ago. Ranking at No. 2945

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -2.45 %

Inmune Bio Inc net loss increased from $-9 millions, to $-9 millions in IV. Quarter 2024,

More on INMB's Growth


Inmune Bio Inc
realized a net loss in trailing twelve months.

Inmune Bio Inc realized cash reduction of $ -0.75 per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 11182.93.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.28.


More on INMB's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 0.78

Inmune Bio Inc
realized net loss in trailing twelve months.

Inmune Bio Inc realized cash outflow of $ -0.75per share in trailing twelve-month period.
Biotechnology & Pharmaceuticals industry recorded net loss in trailing twelve months.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 11182.93.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 6.28.

Inmune Bio Inc Price to Book Ratio is at 4.88 lower than Industry Avg. of 21925.93. and higher than S&P 500 Avg. of 0.01

More on INMB's Valuation

  Market Capitalization (Millions $) 157
  Shares Outstanding (Millions) 20
  Employees 13
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -42
  Cash Flow (TTM) (Millions $) -15
  Capital Exp. (TTM) (Millions $) -
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 0.78

  Market Capitalization (Millions $) 157
  Shares Outstanding (Millions) 20
  Employees 13
  Revenues (TTM) (Millions $) -
  Net Income (TTM) (Millions $) -42
  Cash Flow (TTM) (Millions $) -15
  Capital Exp. (TTM) (Millions $) -





  Ratio
   Capital Ratio (MRQ) 3.14
  Total Debt to Equity (MRQ) -
  Tangible Leverage Ratio (MRQ) 0.48
  Asset Turnover Ratio (TTM) -
  Inventory Turnover Ratio (TTM) -





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com